InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the complete record of transactions filed by Almstead Neil Gregory, Chief Operating Officer. Officer active across 1 companies, notably PTC Therapeutics, INC.. In total, 6 filings have been recorded. Total volume traded: €51k. The latest transaction was filed on 1 February 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€21,551605 shares@ €35.62180.0003% mcap84.9% of flow
Common Stock
SEC:0001179110-22-000835·
€21,551605 shares@ €35.62180.0003% mcap42.5% of flow
Common Stock
SEC:0001179110-22-000835:0·
€1,49343 shares@ €34.7170.0000% mcap5.9% of flow
Common Stock
SEC:0001179110-22-000628·
€1,49343 shares@ €34.7170.0000% mcap2.9% of flow
Common Stock
SEC:0001179110-22-000628:0·
€2,33164 shares@ €36.41930.0000% mcap9.2% of flow
Common Stock
SEC:0001179110-22-000305·
€2,33164 shares@ €36.41930.0000% mcap4.6% of flow
Common Stock
SEC:0001179110-22-000305:0·
6 of 6 declarations
About Almstead Neil Gregory
Neil Gregory Almstead serves as Chief Technical Ops Officer at PTC Therapeutics, Inc. In this role, he oversees the company's technical operations, ensuring efficiency and innovation in product development. Neil Almstead is responsible for implementing technical strategies that support PTC Therapeutics' business objectives. His technical expertise and leadership are essential for the company's ongoing success.
